These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 3128405)

  • 41. Lipid peroxidation in experimental spinal cord injury. Comparison of treatment with Ginkgo biloba, TRH and methylprednisolone.
    Koç RK; Akdemir H; Kurtsoy A; Paşaoğlu H; Kavuncu I; Paşaoğlu A; Karaküçük I
    Res Exp Med (Berl); 1995; 195(2):117-23. PubMed ID: 7659833
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Thyrotropin-releasing hormone analogs.
    Colson AO; Gershengorn MC
    Mini Rev Med Chem; 2006 Feb; 6(2):221-6. PubMed ID: 16472189
    [TBL] [Abstract][Full Text] [Related]  

  • 43. TRH analog YM-14673 improves outcome following traumatic brain and spinal cord injury in rats: dose-response studies.
    Faden AI
    Brain Res; 1989 May; 486(2):228-35. PubMed ID: 2499400
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparison of thyrotropin-releasing hormone (TRH), naloxone, and dexamethasone treatments in experimental spinal injury.
    Faden AI; Jacobs TP; Smith MT; Holaday JW
    Neurology; 1983 Jun; 33(6):673-8. PubMed ID: 6405303
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Opiate antagonist WIN44,441-3 stereospecifically improves neurologic recovery after ischemic spinal injury.
    Faden AI; Jacobs TP
    Neurology; 1985 Sep; 35(9):1311-5. PubMed ID: 4022377
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [New hormone therapy. Thyrotropin releasing hormone].
    Sobue I
    Nihon Rinsho; 1987 Nov; 45(11):2671-8. PubMed ID: 3127616
    [No Abstract]   [Full Text] [Related]  

  • 47. Alternatives to naltrexone in animal models.
    Overstreet DH
    Alcohol Clin Exp Res; 1996 Nov; 20(8 Suppl):231A-235A. PubMed ID: 8947271
    [No Abstract]   [Full Text] [Related]  

  • 48. Thyrotropin-releasing hormone (TRH) effects on spinal cord neuronal excitability.
    White SR; Crane GK; Jackson DA
    Ann N Y Acad Sci; 1989; 553():337-50. PubMed ID: 2497678
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Analogs of thyrotropin-releasing hormone (TRH): receptor affinities in brains, spinal cords, and pituitaries of different species.
    Sharif NA; To ZP; Whiting RL
    Neurochem Res; 1991 Feb; 16(2):95-103. PubMed ID: 1652701
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Thyrotrophin releasing hormone: endocrine and central effects.
    Griffiths EC
    Psychoneuroendocrinology; 1985; 10(3):225-35. PubMed ID: 2865764
    [No Abstract]   [Full Text] [Related]  

  • 51. Effect of thyrotropin-releasing hormone on Na(+)-K(+)-Adenosine triphosphatase activity following experimental spinal cord trauma.
    Baykal S; Ceylan S; Usul H; Aktürk F; Değer O
    Neurol Med Chir (Tokyo); 1996 May; 36(5):296-9. PubMed ID: 8710051
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Analogs of thyrotropin-releasing hormone: hypotheses relating receptor binding to net excitation of spinal lower motor neurons.
    Hawkins EF; Beydoun SR; Haun CK; Engel WK
    Biochem Biophys Res Commun; 1986 Aug; 138(3):1184-90. PubMed ID: 3019335
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Established Stem Cell Model of Spinal Muscular Atrophy Is Applicable in the Evaluation of the Efficacy of Thyrotropin-Releasing Hormone Analog.
    Ohuchi K; Funato M; Kato Z; Seki J; Kawase C; Tamai Y; Ono Y; Nagahara Y; Noda Y; Kameyama T; Ando S; Tsuruma K; Shimazawa M; Hara H; Kaneko H
    Stem Cells Transl Med; 2016 Feb; 5(2):152-63. PubMed ID: 26683872
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Thyrotropin-releasing hormone: basis and potential for its therapeutic use.
    Kelly JA
    Essays Biochem; 1995; 30():133-49. PubMed ID: 8822153
    [No Abstract]   [Full Text] [Related]  

  • 55. The thyrotropin-releasing hormone (TRH) hypothesis of homeostatic regulation: implications for TRH-based therapeutics.
    Gary KA; Sevarino KA; Yarbrough GG; Prange AJ; Winokur A
    J Pharmacol Exp Ther; 2003 May; 305(2):410-6. PubMed ID: 12606661
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of opiate antagonists on middle cerebral artery occlusion infarct in the rat.
    Obana WG; Pitts LH; Nishimura MC
    J Neurosurg; 1988 Jul; 69(1):98-103. PubMed ID: 3132541
    [TBL] [Abstract][Full Text] [Related]  

  • 57. TRH analog administration increases endogenous TRH levels in the central nervous system.
    Prasad C; Eloby-Childress S; Iriuchijima T; Wilber JF; Szirtes T; Kisfaludy L
    Neuroendocrinology; 1989 Feb; 49(2):219-22. PubMed ID: 2542830
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hypotension produced by platelet-activating factor is reversed by thyrotropin-releasing hormone.
    Feuerstein G; Lux WE; Snyder F; Ezra D; Faden AI
    Circ Shock; 1984; 13(3):255-60. PubMed ID: 6432359
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Lack of usefulness of DN-1417 for characterization of a CNS receptor for thyrotropin-releasing hormone.
    Hawkins EF; Wade R; Engel WK
    J Neurochem; 1987 Jul; 49(1):239-45. PubMed ID: 3035097
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of MK-771 on the isolated amphibian spinal cord: comparison with thyrotropin-releasing hormone.
    Yarbrough GG; Singh DK
    Can J Physiol Pharmacol; 1979 Aug; 57(8):920-2. PubMed ID: 115561
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.